G
Gordon W. Philpott
Researcher at Washington University in St. Louis
Publications - 51
Citations - 3708
Gordon W. Philpott is an academic researcher from Washington University in St. Louis. The author has contributed to research in topics: Radiation therapy & Antibody. The author has an hindex of 28, co-authored 51 publications receiving 3642 citations. Previous affiliations of Gordon W. Philpott include Jewish Hospital.
Papers
More filters
Journal ArticleDOI
Factors influencing cosmetic results after conservation therapy for breast cancer
Marie E. Taylor,Carlos A. Perez,Karen J. Halverson,Robert R. Kuske,Gordon W. Philpott,Delia M. Garcia,Joanne E. Mortimer,Robert J. Myerson,Diane M. Radford,Carol Rush +9 more
TL;DR: Host, tumor, and treatment-related factors influencing cosmetic outcome are analyzed for patients receiving breast conservation treatment and it is found that improper orientation of tylectomy and axillary incisions and refinement in surgical/irradiation techniques will enhance the cosmetic results in breast conservation therapy.
Journal Article
Improved radioimaging and tumor localization with monoclonal F(ab')2.
TL;DR: F(ab'),2 fragments offer significant promise for tumor imaging and possibly therapy and in double-label experiments with anti-CEA antibody and control monoclonal IgG, F(ab')2 fragments were found to give better and more rapid specific tumor localization than intact antibody or Fab fragments.
Journal ArticleDOI
The treatment of malignant pleural effusions
TL;DR: Thoracentesis with or without nitrogen mustard instillation was distinctly inferior to the tube and nitrogen mustard method, and pleurectomy in selected cases proved worthwhile.
Journal ArticleDOI
Detection of recurrent and metastatic colorectal cancer: comparison of positron emission tomography and computed tomography.
Olagunju Ogunbiyi,Fidelma L. Flanagan,Farrokh Dehdashti,Barry A. Siegel,Diane D. Trask,Elisa H. Birnbaum,James W. Fleshman,Thomas E. Read,Gordon W. Philpott,Ira J. Kodner +9 more
TL;DR: FDG-PET is more sensitive than CT in the clinical assessment of patients with recurrent or metastatic CRC, and provides an accurate means of selecting appropriate treatment for these patients.
Journal ArticleDOI
Impact of pneumoperitoneum on trocar site implantation of colon cancer in hamster model
Daniel B. Jones,Li Wu Guo,Mary K. Reinhard,Nathaniel J. Soper,Gordon W. Philpott,Judith M. Connett,James W. Fleshman +6 more
TL;DR: Pneumoperitoneum increased implantation of free intra-abdominal cancer cells at wound sites on the abdominal wall or within the abdominal cavity in this animal model, but did not effect recurrence in the liver, lung, or jejunum.